Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Testosterone
Drug ID BADD_D02170
Description Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995] Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.[A187114,L8983,L8935,L8938,L8986,L8989,L8992,L8995] Testosterone was isolated from samples and also synthesized in 1935.[A186943]
Indications and Usage Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995]
Marketing Status approved; investigational
ATC Code G03BA03
DrugBank ID DB00624
KEGG ID D00075
MeSH ID D013739
PubChem ID 6013
TTD Drug ID D06XMU
NDC Product Code 0832-1120; 65089-0050; 43598-304; 49884-418; 63629-8455; 63629-9310; 0591-2925; 38779-2936; 43647-568; 43742-1436; 73774-014; 76003-1083; 43742-1242; 0245-0871; 62332-552; 70700-112; 76420-685; 76420-687; 76420-699; 24979-130; 45802-610; 0051-8462; 64380-151; 68180-943; 69097-363; 0591-2363; 0603-7831; 0009-5020; 44132-006; 49452-7658; 64025-0010; 45802-281; 0245-0872; 0023-5992; 63629-2125; 64380-152; 66887-001; 0591-2114; 0591-2924; 0591-2926; 0591-3216; 0832-1121; 51927-0267; 70492-002; 76420-684; 0009-0074; 12875-8248; 22552-0009; 49452-7652; 60592-721; 60870-0251; 16714-967; 17139-562; 63629-2124; 68180-941; 44132-008; 48087-0113; 51552-0029; 42667-5511; 63481-183; 63629-2352; 69238-1013; 0591-3217; 0591-3524; 38779-0163; 38779-2598; 82393-113; 24979-078; 45802-366; 66887-004; 51552-0564; 62991-2150; 76420-686; 16714-969; 45802-754; 49884-510; 62332-488; 69339-158; 0591-2921; 49452-7657; 16714-968; 0023-5990
UNII 3XMK78S47O
Synonyms Testosterone | 17-beta-Hydroxy-4-Androsten-3-one | 17 beta Hydroxy 4 Androsten 3 one | Androtop | Histerone | Sterotate | Sustanon | Androderm | Testoderm | Testolin | Testopel | Testosterone Sulfate | AndroGel | 8-Isotestosterone | 8 Isotestosterone | 17-beta-Hydroxy-8 alpha-4-Androsten-3-one | 17 beta Hydroxy 8 alpha 4 Androsten 3 one | Andropatch | Testim
Chemical Information
Molecular Formula C19H28O2
CAS Registry Number 58-22-0
SMILES CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nasal discomfort22.12.03.0120.001236%-
Musculoskeletal discomfort15.03.04.0010.000354%-
Thermal burn12.05.04.001; 23.03.11.042--
Vascular occlusion24.04.02.0150.000091%-
Free prostate-specific antigen increased13.23.01.001---
Affect lability19.04.01.001---
Injection site discomfort08.02.03.018; 12.07.03.019---
Transaminases increased13.03.04.036---
Cerebral disorder17.02.10.0170.000182%-
Prostate examination abnormal13.15.01.026---
Haemorrhage24.07.01.002---
Haemorrhage urinary tract20.02.03.005; 24.07.01.007---
Pulmonary mass22.02.07.0040.000382%-
Muscle mass15.05.03.0180.000200%-
Prostate induration21.04.01.006---
Paraesthesia oral07.05.05.035; 17.02.06.008---
Testis cancer16.25.03.001; 21.13.02.0010.000227%-
Cognitive disorder17.03.03.003; 19.21.02.001--
Precocious puberty05.05.03.001; 21.03.02.0090.000827%
Hypogonadism05.05.04.002; 21.03.02.0100.000382%-
Vasodilation procedure25.03.01.001---
Cerebrovascular insufficiency17.08.02.003; 24.04.06.004---
Disturbance in sexual arousal19.08.04.003---
Application site discolouration08.02.01.030; 12.07.01.030; 23.03.03.0230.001390%-
Angiopathy24.03.02.0070.000682%-
Epidermal necrosis23.03.03.035---
Urine output increased13.13.03.002---
Induration08.01.03.020---
Hot flush08.01.03.027; 21.02.02.001; 24.03.01.005--
Ischaemic cerebral infarction17.08.01.022; 24.04.06.0130.000273%-
The 15th Page    First    Pre   15 16 17 18 19    Next   Last    Total 19 Pages